Optimised versus standard dosing of vancomycin in infants with Gram-positive sepsis (NeoVanc): a multicentre, randomised, open-label, phase 2b, non-inferiority trial

L. Hill, Michelle Clements, M. Turner, Daniele Donà, Irja Lutsar, Évelyne Jacqz-Aigrain, Paul T. Heath, Emmanuel Roilides, Louise Rawcliffe, Clara Alonso Díaz, Eugenio Baraldi, Andrea Dotta, Mari‐Liis Ilmoja, Ajit Mahaveer, Tuuli Metsvaht, George Mitsiakos, Vassiliki Papaevangelou, Kosmas Sarafidis, A Sarah Walker, Michael Sharland, L. Hill, Michelle Clements, M. Turner, Daniele Donà, Irja Lutsar, Évelyne Jacqz-Aigrain, Paul T. Heath, Emmanuel Roilides, Louise Rawcliffe, Basma Bafadal, Ana Alarcon Allen, Clara Alonso Díaz, Fani Anatolitou, Eugenio Baraldi, Antonio Del Vecchio, Andrea Dotta, Mario Giuffrè, Mari‐Liis Ilmoja, Korina Karachristou, Ajit Mahaveer, Paolo Manzoni, Stefano Martinelli, Tuuli Metsvaht, George Mitsiakos, Paul Moriarty, Angeliki Nika, Vana Papaevangelou, Charles Christoph Roehr, Laura Sanchez Alcobendas, Kosmas Sarafidis, Tania Siahanidou, Chryssoula Tzialla, Luca Bonadies, Nicola Booth, Paola Catalina Morales-Betancourt, Malaika Cordeiro, Concha de Alba Romero, Javier de la Cruz, Maia De Luca, Daniele Farina, Caterina Franco, Dimitra Gialamprinou, Maarja Hallik, Laura Ilardi, Vincenzo Insinga, Εlias Iosifidis, Riste Kalamees, Angeliki Kontou, Zoltán Molnár, Eirini Nikaina, Chryssoula Petropoulou, Mar Reyné, Kassandra Tataropoulou, Pinelopi Triantafyllidou, Adamantios Vontzalidis, A. Sarah Walker, Mike Sharland